169 related articles for article (PubMed ID: 20466687)
1. Serum protein-bound uraemic toxins and clinical outcomes in haemodialysis patients.
Lin CJ; Wu CJ; Pan CF; Chen YC; Sun FJ; Chen HH
Nephrol Dial Transplant; 2010 Nov; 25(11):3693-700. PubMed ID: 20466687
[TBL] [Abstract][Full Text] [Related]
2. Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration.
Krieter DH; Hackl A; Rodriguez A; Chenine L; Moragues HL; Lemke HD; Wanner C; Canaud B
Nephrol Dial Transplant; 2010 Jan; 25(1):212-8. PubMed ID: 19755476
[TBL] [Abstract][Full Text] [Related]
3. Removal of protein-bound uraemic toxins by haemodialysis.
Niwa T
Blood Purif; 2013; 35 Suppl 2():20-5. PubMed ID: 23676831
[TBL] [Abstract][Full Text] [Related]
4. p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin.
Meijers BK; De Preter V; Verbeke K; Vanrenterghem Y; Evenepoel P
Nephrol Dial Transplant; 2010 Jan; 25(1):219-24. PubMed ID: 19692415
[TBL] [Abstract][Full Text] [Related]
5. Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study.
Brandenburg VM; Schlieper G; Heussen N; Holzmann S; Busch B; Evenepoel P; Vanholder R; Meijers B; Meert N; Fassbender WJ; Floege J; Jahnen-Dechent W; Ketteler M
Nephrol Dial Transplant; 2010 Aug; 25(8):2672-9. PubMed ID: 20172849
[TBL] [Abstract][Full Text] [Related]
6. Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study.
Nakabayashi I; Nakamura M; Kawakami K; Ohta T; Kato I; Uchida K; Yoshida M
Nephrol Dial Transplant; 2011 Mar; 26(3):1094-8. PubMed ID: 20929916
[TBL] [Abstract][Full Text] [Related]
7. Serum total p-cresol and indoxyl sulfate correlated with stage of chronic kidney disease in renal transplant recipients.
Huang ST; Shu KH; Cheng CH; Wu MJ; Yu TM; Chuang YW; Chen CH
Transplant Proc; 2012 Apr; 44(3):621-4. PubMed ID: 22483453
[TBL] [Abstract][Full Text] [Related]
8. Uraemic toxins and cardiovascular disease across the chronic kidney disease spectrum: an observational study.
Rossi M; Campbell K; Johnson D; Stanton T; Pascoe E; Hawley C; Dimeski G; McWhinney B; Ungerer J; Isbel N
Nutr Metab Cardiovasc Dis; 2014 Sep; 24(9):1035-42. PubMed ID: 24880738
[TBL] [Abstract][Full Text] [Related]
9. Removal of P-cresol sulfate by hemodialysis.
Martinez AW; Recht NS; Hostetter TH; Meyer TW
J Am Soc Nephrol; 2005 Nov; 16(11):3430-6. PubMed ID: 16120820
[TBL] [Abstract][Full Text] [Related]
10. Age-dependent increase in serum levels of indoxyl sulphate and p-cresol sulphate is not related to their precursors: Tryptophan and tyrosine.
Wyczalkowska-Tomasik A; Czarkowska-Paczek B; Giebultowicz J; Wroczynski P; Paczek L
Geriatr Gerontol Int; 2017 Jun; 17(6):1022-1026. PubMed ID: 27240996
[TBL] [Abstract][Full Text] [Related]
11. Removal of protein-bound, hydrophobic uremic toxins by a combined fractionated plasma separation and adsorption technique.
Brettschneider F; Tölle M; von der Giet M; Passlick-Deetjen J; Steppan S; Peter M; Jankowski V; Krause A; Kühne S; Zidek W; Jankowski J
Artif Organs; 2013 Apr; 37(4):409-16. PubMed ID: 23330821
[TBL] [Abstract][Full Text] [Related]
12. The removal of protein-bound solutes by dialysis.
Meyer TW
J Ren Nutr; 2012 Jan; 22(1):203-6. PubMed ID: 22200443
[TBL] [Abstract][Full Text] [Related]
13. Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane.
Lesaffer G; De Smet R; Lameire N; Dhondt A; Duym P; Vanholder R
Nephrol Dial Transplant; 2000 Jan; 15(1):50-7. PubMed ID: 10607767
[TBL] [Abstract][Full Text] [Related]
14. Association between uremic toxins and depression in patients with chronic kidney disease undergoing maintenance hemodialysis.
Hsu HJ; Yen CH; Chen CK; Wu IW; Lee CC; Sun CY; Chang SJ; Chou CC; Hsieh MF; Chen CY; Hsu CY; Tsai CJ; Wu MS
Gen Hosp Psychiatry; 2013; 35(1):23-7. PubMed ID: 23044245
[TBL] [Abstract][Full Text] [Related]
15. The role of protein-bound uremic toxins on peripheral artery disease and vascular access failure in patients on hemodialysis.
Lin CJ; Pan CF; Liu HL; Chuang CK; Jayakumar T; Wang TJ; Chen HH; Wu CJ
Atherosclerosis; 2012 Nov; 225(1):173-9. PubMed ID: 22981405
[TBL] [Abstract][Full Text] [Related]
16. Effect of renal transplantation on endothelial function in haemodialysis patients.
Kocak H; Ceken K; Yavuz A; Yucel S; Gurkan A; Erdogan O; Ersoy F; Yakupoglu G; Demirbas A; Tuncer M
Nephrol Dial Transplant; 2006 Jan; 21(1):203-7. PubMed ID: 16144848
[TBL] [Abstract][Full Text] [Related]
17. Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis.
Fagugli RM; De Smet R; Buoncristiani U; Lameire N; Vanholder R
Am J Kidney Dis; 2002 Aug; 40(2):339-47. PubMed ID: 12148107
[TBL] [Abstract][Full Text] [Related]
18. Continuous Reduction of Protein-Bound Uraemic Toxins with Improved Oxidative Stress by Using the Oral Charcoal Adsorbent AST-120 in Haemodialysis Patients.
Yamamoto S; Kazama JJ; Omori K; Matsuo K; Takahashi Y; Kawamura K; Matsuto T; Watanabe H; Maruyama T; Narita I
Sci Rep; 2015 Sep; 5():14381. PubMed ID: 26395517
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with blood concentrations of indoxyl sulfate and p-cresol in patients undergoing peritoneal dialysis.
Lee CT; Kuo CC; Chen YM; Hsu CY; Lee WC; Tsai YC; Ng HY; Kuo LC; Chiou TT; Yang YK; Cheng BC; Chen JB
Perit Dial Int; 2010; 30(4):456-63. PubMed ID: 20338972
[TBL] [Abstract][Full Text] [Related]
20. Effect of the super-flux cellulose triacetate dialyser membrane on the removal of non-protein-bound and protein-bound uraemic solutes.
De Smet R; Dhondt A; Eloot S; Galli F; Waterloos MA; Vanholder R
Nephrol Dial Transplant; 2007 Jul; 22(7):2006-12. PubMed ID: 17468506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
